Roche / Genentech: Clinical Trials & FDA Approval Profile
Roche / Genentech (South San Francisco, CA / Basel, CH) sponsors 353 reconciled interventional Phase II and Phase III ClinicalTrials.gov studies (2018 to 2026), including 158 active protocols (65 recruiting now), 131 completed protocols, and 95 all-time original FDA Drugs@FDA NDA and BLA approvals.